
Topic
Pancreatic Cancer
Podcasts
Tumor Board # 92Nov 17, 2026Multidisciplinary Approaches in Pancreatic Cancer Care

At Cedars-Sinai, the time from a pancreatic cancer diagnosis to the first dose of chemotherapy fell from about a month to 14 days, and trial enrollment nearly tripled, once every specialist started seeing the patient in the same room on the same day. On this episode of the BackTable GI Oncology Creator Weekend™, medical oncologist Dr. Andrew Hendifar of Cedars-Sinai is joined by surgical oncologist Dr. Adam Yopp, chief of surgical oncology at UT Southwestern, and GI medical oncologist Dr. Arsen Osipov of Cedars-Sinai to compare how their same-day multidisciplinary clinics run and what every clinic needs, from an experienced pancreatic surgeon and a radiation oncologist to genetic counseling, an early dietitian visit, and supportive care. They also explain how virtual tumor boards, same-week biopsy slots, and outreach networks bring community oncologists in Texas and California into the plan, and weigh whether pancreatic cancer care should be regionalized, as it is in parts of Canada.
40m
Tumor Board # 90Nov 10, 2026Metastatic Pancreatic Cancer: A New Era of Treatment?

A drug that nearly doubles overall survival in metastatic pancreatic cancer is something Dr. Arsen Osipov says the field has never seen before, and it is why he calls the pan-RAS inhibitor daraxonrasib a paradigm shift on the scale of the first immunotherapy approvals. On this episode of the BackTable GI Oncology Creator Weekend™, host Dr. Andrew Hendifar leads a tumor board on metastatic pancreatic cancer with fellow GI oncologists Dr. Arsen Osipov and Dr. Daniel Ahn. They start with the workup. A CT of the chest, abdomen, and pelvis is usually enough, and a PET rarely changes management. They also cover what to do when a patient does not make CA 19-9, the debate over routine DPYD testing before 5-FU, and why every patient gets molecular profiling.
37m
Tumor Board # 89Nov 2, 2026Perioperative Management of Pancreatic Cancer

Most patients with localized pancreatic cancer already have disease the scans cannot see, which is why these GI oncologists treat chemotherapy before surgery as a test of tumor biology. On this episode of the BackTable GI Oncology Creator Weekend™, medical oncologist Dr. Andrew Hendifar leads a tumor board with GI medical oncologists Dr. Arsen Osipov and Dr. Daniel Ahn on the perioperative management of pancreatic cancer. They explain why nearly every patient with localized disease now starts with chemotherapy rather than surgery, which red flags such as an elevated CA 19-9, enlarged lymph nodes, or profound weight loss point to hidden micrometastatic disease, and why an 80-year-old can still be a candidate for FOLFIRINOX when biological age outweighs chronological age.
35m
Tumor Board # 68Jun 23, 2026Metastatic Pancreatic Cancer: Treatment Options & Trials

Can the latest therapies, lessons from clinical trials, and a focus on emotional support improve outcomes for patients with metastatic pancreatic cancer? In this BackTable Tumor Board episode, GI medical oncologist Dr. Greg Botta and medical oncologist Dr. Dawood Findakly discuss current treatment options, the importance of emotional support, and strategies for overcoming barriers such as insurance delays. They highlight the value of personalized care, from diagnosis and staging scans to tumor markers, tissue biopsy, and genomic profiling, as well as the expanding role of clinical trials and targeted therapies.
48m
Tumor Board # 66Jun 16, 2026Managing Complications in Pancreatic Cancer

How do seasoned clinicians navigate the complex web of complications that accompany pancreatic cancer? In this episode of BackTable Tumor Board, Drs. Greg Botta, Rebekah White, and Zachary Berman discuss real-world strategies for managing pain, digestive complications, and the many challenges patients face. They explore multidisciplinary approaches, emphasizing the importance of tailored pain management, careful use of enzyme supplementation, and anticipating both surgical and medical risks, especially after procedures like the Whipple.
42m
Tumor Board # 62Jun 2, 2026Advancements in Managing Locally Advanced Pancreatic Cancer

Can a tumor deemed permanently unresectable actually be downstaged to surgery? In this episode of BackTable Tumor Board, host Dr. Zach Berman (interventional radiologist, UC San Diego) is joined by Dr. Rebekah White (surgical oncologist) and Dr. Michael Sherer (radiation oncologist) to discuss the complexities of managing locally advanced, unresectable pancreatic cancer and evaluate how individualized patient factors, treatment response, and multidisciplinary expertise can turn inoperable tumors into surgical candidates.
37m
Curbsiders # 526May 25, 2026DIGEST – Game Changers in Pancreatic Cancer, Lipid Guideline Updates & GLP-1/GIP Endoscopy Holds

Join us as we review recent articles and news featured in The DIGEST, including updated lipid guidelines, GLP1 agonists holds and procedures, the newest drug in pancreatic cancer, and discontinuing thyroid supplementation. Fill your brain hole with a delicious stack of hotcakes! Featuring Drs. Nora Taranto (@norataranto), Laura Glick (@lauraglick) and Matt Watto (@doctorwatto).
56m